Hsp90 has, in addition to ErbB2, a number of other client proteins, including Akt, that control cell growth [10,13,14], and GA-derivatives such as 17-allylamino-17-demethoxygeldanamycin (17-AAG) are currently in development for cancer treatment [15]. The gene discussed is ERBB2; the disease is cancer.